Serum-Free Astrocyte Differentiation for Mature Neural Models

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods for generating human astrocytes from pluripotent stem cells are time-intensive, require serum that activates astrocytes, lack reproducibility, and fail to adequately mature astrocytes for studying neurological diseases.

Innovation Solution

A method involving the culture of human neural stem cells from induced pluripotent stem cells in serum-free conditions using specific media and markers to produce mature astrocytes, characterized by markers such as GFAP and AQP4, and co-cultured with microglia to study neurological diseases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If serum is used in culture media to generate astrocytes, then cell growth and marker expression are enhanced, but astrocyte activation occurs making it difficult to study healthy function

Engineering Contradiction:

Improveastrocyte generation efficiencyVSAvoidastrocyte activation

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent removes serum from the culture media, extracting the harmful component that causes astrocyte activation while maintaining essential growth factors and cytokines needed for astrocyte differentiation and maturation

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical composition parameters of the culture media by replacing serum-containing formulations with defined serum-free media containing specific growth factors (EGF, FGF2, BDNF, GDNF, IGF-1, CNTF) and cytokines, thereby eliminating activation while preserving productivity

Inventive Principle:

Principle #35Parameter changes

2Manufacturing precision

If traditional differentiation protocols are used to generate astrocytes from pluripotent stem cells, then astrocyte markers are expressed, but the process takes over 6 months and produces immature astrocytes

Engineering Contradiction:

Improveastrocyte maturation qualityVSAvoiddifferentiation time

Core Design Contradiction:

Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary actions by pre-differentiating cells into neural progenitor cells with astroglial characteristics before final astrocyte differentiation, and by pre-establishing optimal culture conditions with specific growth factors and cytokines to accelerate maturation

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent maintains continuous exposure to essential growth factors (EGF, FGF2) and cytokines throughout the differentiation process, ensuring uninterrupted signaling for astrocyte maturation and preventing differentiation stalls that extend timeline

Inventive Principle:

Principle #20Continuity of useful action

3Reliability

If commercial media sources containing FBS are used, then astrocyte markers are expressed, but the phenotype becomes reactive and unreliable for studying healthy function

Engineering Contradiction:

Improveastrocyte phenotype consistencyVSAvoidreactive astrocyte phenotype

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent removes fetal bovine serum (FBS) from the culture media, extracting the component that induces reactive astrocyte phenotype while retaining essential nutrients and growth factors through defined serum-free formulations

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the media composition parameters by replacing undefined serum-based media with defined serum-free media containing specific concentrations of growth factors and cytokines, thereby achieving reliable, reproducible astrocyte phenotypes suitable for studying healthy function

Inventive Principle:

Principle #35Parameter changes

Data Source

PatentUS20250382570A1Generation and application of functional human astrocytes from pluripotent stem cells

Publication Date: 2025.12.18 RGT UNIV OF CALIFORNIA

AI summary

A method of producing human astrocytes from neural stem cells (NSCs) involves providing induced progenitor cells (iPSCs), differentiating iPSCs to neural stem cells (NSCs), and differentiating NSCs to astrocytes.